title: Reducing neurotoxicity in the management of multiple myeloma.
authors: Mayo Clinic, Rochester, MN, USA. gertm@mayo.edu
authors: Morie A
authors: MA
authors: Gertz
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects*; D009101:Multiple Myeloma / Q000188:drug therapy*; D009422:Nervous System Diseases / Q000139:chemically induced*; D016879:Salvage Therapy; D013792:Thalidomide / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D007155:Immunologic Factors; D013792:Thalidomide